New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2013
14:51 EDTARNIArno Therapeutics to present data on two potential predictive biomarkers
Arno Therapeutics announced that data from a biomarker study supporting its lead compound onapristone will be presented at a poster session at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium, SABCS, annual meeting, being held December 10-14, in San Antonio, Texas. The symposium is hosted by the American Association for Cancer Research, The Cancer Therapy & Research Center at The University of Texas Health Sciences Center at San Antonio, and Baylor College of Medicine. Findings from the study "Tumor and Cellular Distribution of Activated Forms of ERa and PR in Breast Cancers" will be presented during Poster Session 6 on Tumor Cell and Molecular Biology: Biomarkers on Saturday, December 14. Data analysis from primary breast cancers further support the development of a diagnostic test to identify patient tumors with activated progesterone receptor, APR, and activated estrogen receptor, AER, as potential biomarkers of anti-progestin and anti-estrogen activity, respectively.
News For ARNI From The Last 14 Days
Check below for free stories on ARNI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ARNI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use